Patents by Inventor Guoquan Xu

Guoquan Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12250142
    Abstract: A method is applied to a network comprising a first area and a second area. A first node in the first area obtains aggregated routing information, where the aggregated routing information is obtained by aggregating a plurality of pieces of original routing information, the plurality of pieces of original routing information correspond to N nodes in a network segment, the N nodes in the network segment have a same flexible algorithm flex-algo, and the aggregated routing information carries an algorithm identifier used to indicate the flex-algo and a network segment identifier used to indicate the network segment. The first node sends the aggregated routing information to the second area, where the aggregated routing information is used to indicate a node in the second area to send a packet to the N nodes in the network segment based on the aggregated routing information.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: March 11, 2025
    Assignee: HUAWEI TECHONLOGIES CO., LTD.
    Inventors: Ruqin Lan, Guoqi Xu, Chuang Chen, Guoquan Liu, Zuliang Wang
  • Patent number: 10221178
    Abstract: The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: March 5, 2019
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Meredeth Ann McGowan, Hua Zhou, Jason D. Katz, Lihu Yang, Joey L. Methot, Kathryn Ann Lipford, Shimin Xu, Ning Fu, Guoquan Xu, Deqian Bian, Jianmin Fu, Yabin Li, Kin Chiu Fong
  • Publication number: 20180141947
    Abstract: The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
    Type: Application
    Filed: June 24, 2016
    Publication date: May 24, 2018
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Meredith Ann McGowan, Hua Zhou, Jason D. Katz, Lihu Yang, Joey L. Methot, Kathryn Ann Lipford, Shimin Xu, Ning Fu, Guoquan Xu, Deqian Bian, Jianmin Fu, Yabin Li, Kin Chiu Fong